• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从CD34+造血祖细胞产生的树突状细胞亚群可以用mRNA转染并诱导抗原特异性细胞毒性T细胞反应。

Dendritic cell subsets generated from CD34+ hematopoietic progenitors can be transfected with mRNA and induce antigen-specific cytotoxic T cell responses.

作者信息

Ueno Hideki, Tcherepanova Irina, Reygrobellet Olivier, Laughner Erik, Ventura Claire, Palucka A Karolina, Banchereau Jacques

机构信息

Baylor Institute for Immunology Research, 3434 Live Oak, Dallas, TX 75204, USA.

出版信息

J Immunol Methods. 2004 Feb 15;285(2):171-80. doi: 10.1016/j.jim.2003.11.012.

DOI:10.1016/j.jim.2003.11.012
PMID:14980432
Abstract

Human dendritic cells (DCs) generated in culture from either monocytes or CD34+ hematopoietic progenitor cells (CD34-HPCs) have been used in cancer immunotherapy protocols with encouraging results. Yet an optimal strategy for the delivery of antigen(s) to DCs still remains to be established. Recent studies demonstrated the feasibility of mRNA transfection to load monocyte-derived DCs. It is not known, however, whether DCs derived by culturing CD34-HPC with GM-CSF and TNF-alpha for 9 days (CD34-DCs) can be efficiently transduced with mRNA. Here we show that clinical-grade CD34-DCs generated after 8 days of culture can be transfected with mRNA without significant alteration of cell viability. About 90% of cells transfected with GFP-RNA express GFP 24 h post-transfection. Remarkably, transfected CD34-DCs retain high levels of GFP expression for at least 14 days. CD34-DCs transfected with Flu-MP RNA were highly efficient in inducing the proliferation of Flu-MP-specific CD8+ T cells as measured by tetramer staining. Furthermore, the stimulated CD8+ T cells produced IFN-gamma upon antigenic stimulation and were able to kill targets pulsed with Flu-MP peptide. Both DC subsets in CD34-DCs, CD1a+-DC (Langerhans cells) and CD14+-DC (interstitial DC), were equally transfected with GFP-RNA, and yielded Flu-specific cytotoxic T cells upon transfection with Flu-MP RNA. Thus, RNA can be used to deliver antigens to two distinct myeloid DC subsets in CD34-DC cultures.

摘要

从单核细胞或CD34⁺造血祖细胞(CD34⁺-HPCs)体外培养产生的人树突状细胞(DCs)已被用于癌症免疫治疗方案,并取得了令人鼓舞的结果。然而,将抗原递送至DCs的最佳策略仍有待确立。最近的研究证明了mRNA转染加载单核细胞来源DCs的可行性。然而,尚不清楚用GM-CSF和TNF-α培养9天产生的DCs(CD34-DCs)是否能被mRNA有效转导。在这里,我们表明培养8天后产生的临床级CD34-DCs可以用mRNA转染,而细胞活力无明显改变。转染GFP-RNA的细胞中约90%在转染后24小时表达GFP。值得注意的是,转染的CD34-DCs至少14天保持高水平的GFP表达。用Flu-MP RNA转染的CD34-DCs在通过四聚体染色测量时,在诱导Flu-MP特异性CD8⁺ T细胞增殖方面非常高效。此外,受刺激的CD8⁺ T细胞在抗原刺激后产生IFN-γ,并能够杀死用Flu-MP肽脉冲处理的靶细胞。CD34-DCs中的两个DC亚群,CD1a⁺-DC(朗格汉斯细胞)和CD14⁺-DC(间质DC),均被GFP-RNA同等转染,并在用Flu-MP RNA转染后产生Flu特异性细胞毒性T细胞。因此,RNA可用于将抗原递送至CD34-DC培养物中的两个不同髓样DC亚群。

相似文献

1
Dendritic cell subsets generated from CD34+ hematopoietic progenitors can be transfected with mRNA and induce antigen-specific cytotoxic T cell responses.从CD34+造血祖细胞产生的树突状细胞亚群可以用mRNA转染并诱导抗原特异性细胞毒性T细胞反应。
J Immunol Methods. 2004 Feb 15;285(2):171-80. doi: 10.1016/j.jim.2003.11.012.
2
Retroviral-mediated IL-12 gene transduction into human CD34+ cell-derived dendritic cells.逆转录病毒介导的白细胞介素-12基因转导入人CD34+细胞来源的树突状细胞。
Int J Oncol. 2002 Sep;21(3):509-14.
3
Generation of Ag-specific cytotoxic T lymphocytes by DC transfected with in vitro transcribed influenza virus matrix protein (M1) mRNA.用体外转录的流感病毒基质蛋白(M1)mRNA转染的树突状细胞产生抗原特异性细胞毒性T淋巴细胞。
Cytotherapy. 2003;5(2):161-8. doi: 10.1080/14653240310001064.
4
Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3.通过白细胞介素-6和白细胞介素-3从CD34+细胞中选择性生成不同的树突状细胞前体。
Stem Cells. 2004;22(5):725-40. doi: 10.1634/stemcells.22-5-725.
5
Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes.用编码流感病毒基质蛋白M1的RNA或DNA转染的人树突状细胞在刺激细胞毒性T淋巴细胞的能力上存在差异。
Gene Ther. 2000 Dec;7(23):2028-35. doi: 10.1038/sj.gt.3301326.
6
CD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapy.CD40配体在RNA脉冲树突状细胞免疫疗法中对于产生特异性细胞毒性T细胞反应至关重要。
Surgery. 2003 Aug;134(2):300-5. doi: 10.1067/msy.2003.240.
7
Dendritic cells generated either from CD34+ progenitor cells or from monocytes differ in their ability to activate antigen-specific CD8+ T cells.由CD34+祖细胞或单核细胞产生的树突状细胞在激活抗原特异性CD8+T细胞的能力上存在差异。
J Immunol. 1999 Oct 1;163(7):3597-604.
8
Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.外周血干细胞移植背景下基于树突状细胞的疫苗:去除CD34+细胞的动员外周血可作为高效树突状细胞的来源。
Clin Cancer Res. 1998 Nov;4(11):2709-16.
9
Dendritic cell generated from CD34+ hematopoietic progenitors can be transfected with adenovirus containing gene of HBsAg and induce antigen-specific cytotoxic T cell responses.从CD34+造血祖细胞生成的树突状细胞可以用含有乙肝表面抗原(HBsAg)基因的腺病毒进行转染,并诱导抗原特异性细胞毒性T细胞反应。
Cell Immunol. 2006 Mar;240(1):14-21. doi: 10.1016/j.cellimm.2006.06.005. Epub 2006 Jul 27.
10
Green fluorescent protein expression in dendritic cells enhances their immunogenicity and elicits specific cytotoxic T-cell responses in humans.树突状细胞中绿色荧光蛋白的表达增强了它们的免疫原性,并在人体中引发特异性细胞毒性T细胞反应。
Exp Hematol. 2004 Feb;32(2):210-7. doi: 10.1016/j.exphem.2003.10.014.

引用本文的文献

1
Dendritic Cell Therapies for Hematologic Malignancies.用于血液系统恶性肿瘤的树突状细胞疗法
Mol Ther Methods Clin Dev. 2017 Mar 18;5:66-75. doi: 10.1016/j.omtm.2017.03.004. eCollection 2017 Jun 16.
2
Generation of immunogenic and tolerogenic clinical-grade dendritic cells.免疫原性和耐受性临床级树突状细胞的生成。
Immunol Res. 2011 Dec;51(2-3):153-60. doi: 10.1007/s12026-011-8255-5.
3
Studies on mRNA electroporation of immature and mature dendritic cells: effects on their immunogenic potential.未成熟和成熟树突状细胞的mRNA电穿孔研究:对其免疫原性潜力的影响。
Mol Biotechnol. 2008 Oct;40(2):151-60. doi: 10.1007/s12033-008-9071-6. Epub 2008 Jun 10.
4
Human Langerhans' cells and dermal-type dendritic cells generated from CD34 stem cells express different toll-like receptors and secrete different cytokines in response to toll-like receptor ligands.从CD34干细胞生成的人类朗格汉斯细胞和真皮型树突状细胞表达不同的 Toll 样受体,并在对 Toll 样受体配体作出反应时分泌不同的细胞因子。
Immunology. 2008 Jul;124(3):329-38. doi: 10.1111/j.1365-2567.2007.02770.x. Epub 2008 Jan 11.
5
Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34(+) progenitor-derived dendritic cells.接种黑色素瘤肽脉冲CD34(+)祖细胞衍生树突状细胞的转移性黑色素瘤患者的长期预后
Cancer Immunol Immunother. 2006 Oct;55(10):1209-18. doi: 10.1007/s00262-005-0106-6. Epub 2005 Dec 6.
6
New developments in dendritic cell-based vaccinations: RNA translated into clinics.基于树突状细胞的疫苗接种新进展:RNA转化为临床应用。
Cancer Immunol Immunother. 2005 Jun;54(6):517-25. doi: 10.1007/s00262-004-0605-x. Epub 2005 Jan 27.
7
Evaluation of dendritic cells loaded with apoptotic cancer cells or expressing tumour mRNA as potential cancer vaccines against leukemia.评估负载凋亡癌细胞或表达肿瘤mRNA的树突状细胞作为抗白血病潜在癌症疫苗的效果。
BMC Cancer. 2005 Feb 18;5:20. doi: 10.1186/1471-2407-5-20.